1. Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetic Medicine. 1998;15(7):539-53. https://doi.org/10.1002/(sici)1096-9136(199807)15:7%3C539::aid-dia668%3E3.0.co;2-s.
2. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart disease and stroke statistics—2014 update: a report from the American Heart Association. Circulation. 2014;129(3):e28-e292. https://doi.org/10.1161/01.cir.0000441139.02102.80.
3. Schwingshackl L, Hoffmann G. Comparison of the long-term effects of high-fat v. low-fat diet consumption on cardiometabolic risk factors in subjects with abnormal glucose metabolism: a systematic review and meta-analysis. British Journal of Nutrition. 2014;111(12):2047-58. https://doi.org/10.1017/s0007114514000464.
4. Deloux R, Vitiello D, Mougenot N, Noirez P, Li Z, Mericskay M, et al. Voluntary exercise improves cardiac function and prevents cardiac remodeling in a mouse model of dilated cardiomyopathy. Front in Physiology. 2017;8:899. https://doi.org/10.3389/fphys.2017.00899.
5. McMullen JR, Jennings GL. Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure. Clinical and Experimental Pharmacology & Physiology. 2007;34(4):255-62. https://doi.org/10.1111/j.1440-1681.2007.04585.x.
6. Nakamura M, Sadoshima J. Mechanisms of physiological and pathological cardiac hypertrophy. Nature Reviews Cardiology. 2018;15(7):387-407. https://doi.org/10.1038/s41569-018-0007-y.
7. Shimizu I, Minamino T. Physiological and pathological cardiac hypertrophy. Journal of Molecular and Cellular Cardiology. 2016;97:245-62. https://doi.org/10.1016/j.yjmcc.2016.06.001.
8. Lu S, Liao Z, Lu X, Katschinski DM, Mercola M, Chen J, et al. Hyperglycemia acutely increases cytosolic reactive oxygen species via O-linked GlcNAcylation and CaMKII activation in mouse ventricular myocytes. Circulation Research. 2020;126(10):e80-e96. https://doi.org/10.1161/circresaha.119.316288.
9. Wang L-H, Wang Y-Y, Liu L, Gong Q. From diabetes to diabetic complications: role of autophagy. Current Medical Science. 2023;43(3):434-44. https://doi.org/10.1007/s11596-023-2727-4.
10. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey Jr DE, Drazner MH, et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;128(16):1810-52. https://doi.org/10.1161/cir.0b013e31829e8807.
11. Mohammadi S, Monazzami A. Effects of eight-week high-intensity interval training on some metabolic, hormonal and cardiovascular indices in women with PCOS: a randomized controlled trail. BMC Sports Science, Medicine and Rehabilitation. 2023;15(1):1-11. https://doi.org/10.1186/s13102-023-00653-z.
12. Gibala MJ, Little JP, MacDonald MJ, Hawley JA. Physiological adaptations to low‐volume, high‐intensity interval training in health and disease. The Journal of Physiology. 2012;590(5):1077-84. https://doi.org/10.1113/jphysiol.2011.224725.
13. Lu Z, Xu Y, Song Y, Bíró I, Gu Y. A mixed comparisons of different intensities and types of physical exercise in patients with diseases related to oxidative stress: a systematic review and network meta-analysis. Frontiers in Physiology. 2021;12:700055. https://doi.org/10.3389/fphys.2021.700055.
14. Quindry JC, Miller L, McGinnis G, Kliszczewicz B, Irwin JM, Landram M, et al. Ischemia reperfusion injury, KATP channels, and exercise-induced cardioprotection against apoptosis. Journal of Applied Physiology (1985). 2012;113(3):498-506. https://doi.org/10.1152/japplphysiol.00957.2011.
15. Khajehlandi M, Bolboli L. The role of quercetin and exercise in modulating apoptosis and cardiomyopathy via PI3K/AKT/FOXO3 pathways in diabetic obese rats. Cell Journal. 2025;26(9):559-68. https://doi.org/10.22074/cellj.2024.2042044.1682.
16. Aghaei Bahman Beglou N, Shadmehri S, Jahani Golbar S, Sharafati Moghadam M. The effect of four weeks high-intensity interval training (HIIT) on the content of AKT1, mTOR, P70S6K1, 4EBP1 proteins in the Left ventricular muscle tissue of the heart obese rats with type 2 diabetic. Journal of Sport and Exercise Physiology. 2021;14(1):85-94. [In Persian]. https://doi.org/10.52547/joeppa.14.1.85.
17. Alvarez C, Ramirez-Campillo R, Martinez-Salazar C, Mancilla R, Flores-Opazo M, Cano-Montoya J, et al. Low-volume high-intensity interval training as a therapy for type 2 diabetes. International Journal of Sports Medicine. 2016;37(9):723-9. https://doi.org/10.1055/s-0042-104935.
18. Hansen D, Dendale P, Jonkers RA, Beelen M, Manders RJ, Corluy L, et al. Continuous low- to moderate-intensity exercise training is as effective as moderate- to high-intensity exercise training at lowering blood HbA(1c) in obese type 2 diabetes patients. Diabetologia. 2009;52(9):1789-97. https://doi.org/10.1007/s00125-009-1354-3.
19. Lee MR, Kim JE, Choi JY, Park JJ, Kim HR, Song BR, et al. Anti‑obesity effect in high‑fat‑diet‑induced obese C57BL/6 mice: Study of a novel extract from mulberry (Morus alba) leaves fermented with Cordyceps militaris. Experimental and Therapeutic Medicine. 2019;17(3):2185-93. https://doi.org/10.3892/etm.2019.7191.
20. Eliza J, Daisy P, Ignacimuthu S, Duraipandiyan V. Antidiabetic and antilipidemic effect of eremanthin from Costus speciosus (Koen.) Sm., in STZ-induced diabetic rats. Chemico-Biological Interactions. 2009;182(1):67-72. https://doi.org/10.1016/j.cbi.2009.08.012.
21. Marcinko K, Sikkema SR, Samaan MC, Kemp BE, Fullerton MD, Steinberg GR. High intensity interval training improves liver and adipose tissue insulin sensitivity. Molecular Metabolism. 2015;4(12):903-15. https://doi.org/10.1016/j.molmet.2015.09.006.
22. Orumiyehei A, Khoramipour K, Rezaei MH, Madadizadeh E, Meymandi MS, Mohammadi F, et al. High-intensity interval training-induced hippocampal molecular changes associated with improvement in anxiety-like behavior but not cognitive function in rats with type 2 diabetes. Brain Sciences. 2022;12(10):1280. https://doi.org/10.3390/brainsci12101280.
23. Bancroft JD, Gamble M. Theory and practice of histological techniques. Philadelphia: Elsevier Health Sciences. 2008. https://doi.org/10.1016/b978-0-443-10279-0.50004-x.
24. Kanashiro-Takeuchi RM, Takeuchi LM, Rick FG, Dulce R, Treuer AV, Florea V, et al. Activation of growth hormone releasing hormone (GHRH) receptor stimulates cardiac reverse remodeling after myocardial infarction (MI). Proceedings of the National Academy of Sciences. 2012;109(2):559-63. https://doi.org/10.1016/b978-0-443-10279-0.50004-x.
25. Novoa U, Arauna D, Moran M, Nuñez M, Zagmutt S, Saldivia S, et al. High-intensity exercise reduces cardiac fibrosis and hypertrophy but does not restore the nitroso-redox imbalance in diabetic cardiomyopathy. Oxidative Medicine and Cellular Longevity. 2017;2017:7921363. https://doi.org/10.1155/2017/7921363.
26. Rami M, Rahdar S, Ahmadi Hekmatikar A, Awang Daud DM. Highlighting the novel effects of high-intensity interval training on some histopathological and molecular indices in the heart of type 2 diabetic rats. Frontiers in Endocrinology. 2023;14:1175585. https://doi.org/10.3389/fendo.2023.1175585.
27. Amri J, Parastesh M, Sadegh M, Latifi SA, Alaee M. High-intensity interval training improved fasting blood glucose and lipid profiles in type 2 diabetic rats more than endurance training; possible involvement of irisin and betatrophin. Physiology International. 2019;106(3):213-24. https://doi.org/10.1556/2060.106.2019.24.
28. Li H, Luo ZR, Huang MY, Cai H, Lu PP, Xu YW, et al. Modified taohong siwu decoction improved cardiac function after myocardial infarction by activating PI3K/Akt signaling pathway. Current Pharmaceutical Design. 2025. https://doi.org/10.2174/0113816128341178241028062518.
29. Lakshmipathi J, Alvarez-Perez JC, Rosselot C, Casinelli GP, Stamateris RE, Rausell-Palamos F, et al. PKCζ is essential for pancreatic β-Cell replication during insulin resistance by regulating mTOR and cyclin-D2. Diabetes. 2016;65(5):1283-96. https://doi.org/10.2337/db15-1398.
30. Liu PJ, Hu YS, Wang MJ, Kang L. Nutrient weight against sarcopenia: regulation of the IGF-1/PI3K/Akt/FOXO pathway in quinoa metabolites. Current Opinion in Pharmacology. 2021;61:136-41. https://doi.org/10.1016/j.coph.2021.10.001.
31. Yuan G, Qin Y, Peng P. High-intensity interval training for treating pathological cardiac hypertrophy in spontaneously hypertensive rats: effects and mechanisms. Chinese Journal of Tissue Engineering Research. 2020;24(23):3708. https://doi.org/10.3969/j.issn.2095-4344.2692.
32. Huang X, Liu G, Guo J, Su Z. The PI3K/AKT pathway in obesity and type 2 diabetes. International Journal of Biological Sciences. 2018;14(11):1483. https://doi.org/10.7150/ijbs.27173.
33. Kemi OJ, Ceci M, Wisloff U, Grimaldi S, Gallo P, Smith GL, et al. Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy. Journal of Cellular Physiology. 2008;214(2):316-21. https://doi.org/10.1002/jcp.21197.
34. Pelozin BR, Soci UP, Gomes JL, Oliveira EM, Fernandes T. mTOR signaling-related microRNAs as cardiac hypertrophy modulators in high-volume endurance training. Journal of Applied Physiology. 2022;132(1):126-39. https://doi.org/10.1152/japplphysiol.00881.2020.